drugset / Trial / NCT03150420

A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients

NCT03150420

Phase 3 Terminated 29 enrolled Hope Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This multicenter, randomized, double-blind, placebo-controlled clinical trial will evaluate the efficacy and safety of intravenous Sodium Thiosulfate Injection for treatment of acute calciphylaxis-associated pain in chronic hemodialysis patients.

Timeline

Start
2017-05-24
Primary completion
2020-04-15
Completion
2020-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Sodium Thiosulfate Diagnostic / imaging agent 25 g Intravenous

Indications